Revista de Farmacologia Clínica e Experimental

Abstrato

Overview and Innovation of Ovarian Cancer in Developed and Developing Country

Saritha Surapaneni, Narayana Swamy VB, Pooja Jain VN

Ovarian cancer is referred as impairment due to asymptomatic existence. It is task for oncologist because of its serious health conditions. Most cancer is a crew of illness which is caused by means of multiplication or increase of cells, i.e. in out of control and spread to different a part of the body. They additionally recognized as â€oeSilent killer†also refer as ‘Ovarian carcinoma’. It is a deadly disease mostly involved in women over 40 years of age or upto 55-64. It is the 6^th common tumor. In 20’s and 30’s of age it is exceedingly rare to occur. Some studies recognize that, now a day’s pregnant ladies also diagnosed with ovarian cancer. Adnexal tumor is identified in most of the cases. They show that malignancy is rising in the course of pregnancy. In every year, more than 200,000 new instances are identified. Ovarian cancer often goes undetected until it has spread within the pelvis and stomach. At that last stage, it is more difficult to treat and can be fatal. Because ovarian cancer has no symptoms in the early stage’s treatment will be delayed. Its treatment will depend on stages. Surgery and chemotherapy are generally used to treat ovarian cancer. Chemotherapy was done by administration of 6 cycles of intravenous with Carboplatin and Paclitaxel along with radiation therapy and also some other drugs which used in the treatment are Metformin, Bevacizumab. Novel targeted therapies are the advanced treatment for screening and understanding of ovarian cancer. In targeted therapies mainly Nanotechnology based drugs are developed for reduction of toxicity and side effects. The article aims to analyse the recent studies and review on general information such as epidemiology, symptoms, risk factors, early detection, imaging or screening, diagnosis, staging, prevention, management and recent studies. The paper also aims to provide insight into the quality-of-life concerns of ovarian cancer patients such as how the treatment will affect the patient, how they survive, support services, society and also discuss about how the current situation COVID-19 will affect the patients.